One drink is enough to wreck your HRV
Fitbit Air Launches at $99; Smart Rings Add Haptics and Blood Pressure
Google launched the Fitbit Air at $99 — a 12g screenless band with optical HR, SpO2, skin temperature, and AFib detection; 7-day battery; 50m water resistance; preorders open now with shipping by end of May (previously reported as ~May 16 — announced earlier) (TechRadar, Tom's Guide). No subscription required for core features; includes a 3-month Google Health Premium trial.
The Fitbit app becomes the Google Health app in a mandatory May 19 rollout — Fitbit Premium rebrands to Google Health Premium at the same price; the AI Health Coach exits beta and can ingest medical records alongside biometric and nutrition data (The Verge). Google confirmed plans to eventually support third-party devices including Garmin, WHOOP, and Oura.
WHOOP released its Navigator Band at $79, an abrasion-resistant, no-slip outdoor strap built in response to years of user reports of bands detaching during surfing, climbing, and other high-impact activities; compatible only with WHOOP 5.0 and MG, not 4.0 (Gear Patrol).
RingConn Gen 3 launched May 5 as the first smart ring with haptic feedback via an integrated vibration motor, plus AI-derived blood pressure risk assessment (analyzing HR, SpO2, skin temp, and motion — not a cuff-grade direct measurement); 10+ day battery; no subscription for core functions; price not yet announced (Basic Tutorials).
Ultrahuman Ring Pro opened a Kickstarter at up to 43% off ($349 Early Bird), crossing $168K vs. a $10K goal within days — Kickstarter orders ship June 2026, compared to the May 15 direct preorder date reported last issue (Yahoo Tech).
Oura Addresses Hormonal Health; WHOOP Wins U.S. Navy Contract
Oura is rolling out Hormonal Birth Control support and Menopause Insights in a May 6 update — BC support maps how contraception method (pill, patch, IUD) influences temperature baselines, sleep, and recovery over time; Menopause Insights delivers a personalized symptom dashboard for clinician sharing (Android Central).
WHOOP won a U.S. Navy contract through MIT Lincoln Laboratory to integrate WHOOP into the CREW (Command Readiness, Endurance and Watchstanding) fatigue monitoring program — following WHOOP's prior protests that derailed Oura's contested $96M DoD contract; Oura maintains a separate broad DoD partnership and Fort Worth manufacturing facility (MobiHealthNews).
Two WHOOP studies published this week found even one drink measurably lowers HRV and raises overnight RHR; a separate 30,000-member longitudinal study over 72 weeks showed a 25.2% relative decline in daily drinking probability and ~1.1 fewer drinks per week among members consistently seeing the physiological impact (WHOOP research release). Published in PLOS Digital Health and JMIR mHealth; observational design, not randomized. Females showed greater physiological disruption than males at comparable intake levels.
Galaxy Watch Predicts Fainting; Sweat Patches Now Track Vitamins
Galaxy Watch6 predicted vasovagal syncope with 84.6% accuracy up to 5 minutes before episodes in a 132-patient clinical study with Chung-Ang University Hospital — the first commercial smartwatch to demonstrate real-time fainting prediction; the model analyzed PPG-derived HRV with an AI algorithm (Samsung Newsroom). Published in European Heart Journal – Digital Health.
A wearable sweat patch detected 6 vitamins in real time via iontophoresis-induced sweat collection and electrochemical sensing (Nature Communications, April 28); sweat vitamin B9 correlated with serum levels at r=0.849 and spiked 3.6× within hours of a 5mg supplement (News-Medical). Only B9 was validated in-body in a small young-adult cohort; not yet clinically interchangeable with blood testing.
Wrist-worn HRV is most useful as a trending tool, not an absolute benchmark — chest straps remain the accuracy reference standard; WHOOP population data shows HRV declining from ~78ms at age 25 to ~44ms at age 55, and a depressed personal reading is more actionable than comparison to population averages (BBC).
PBM: Too Much Light Backfires; Oral Applications Enter Mainstream
Excessive irradiance in red light devices can generate reactive oxygen species, triggering inflammation rather than repair — a documented risk identified by New Scientist alongside a summary of the current strongest evidence: acne (79% pimple reduction at 12 weeks in one study), androgenetic alopecia (+57% hair density in one trial), wound healing, and an emerging blood sugar signal (red light may improve glucose-to-ATP conversion efficiency) (New Scientist). 200+ clinical trials are currently active.
UCL neuroscientist Prof. Glen Jeffery told the BBC that home red light beds "may not have the correct mix of wavelengths" for effective mitochondrial stimulation; near-infrared penetrates to muscle tissue while red light stays at the skin/dermis boundary, meaning device specs — not wavelength marketing claims — determine depth of effect (BBC).
PBM clinical trials targeting Alzheimer's and Parkinson's are active as of May 2026, based on the mechanism that 650–850nm wavelengths stimulate cytochrome c oxidase to increase ATP and reduce systemic inflammation; Grenoble Alpes researcher John Mitrofanis notes peer-reviewed publication volume in this area has grown from ~10 per year to thousands (AsatuNews citing University of Grenoble Alpes and UCL). No human outcome data yet.
Oral PBM at 630nm + 850nm is gaining clinical validation for gum tissue — cytochrome c oxidase receptors in gum cells absorb both wavelengths; NIR reaches deeper oral structures; functional dentist Dr. Stacy Whitman confirmed the wavelength range and recommended applying on clean tissue post-hygiene routine at night (healthHackers via YouTube). Clinical guidelines have included oral PBM for cancer therapy-related oral mucositis since 2020.
Cold Plunge Neurochemistry: The Norepinephrine Mechanism
CWI simultaneously triggers dopamine, serotonin, norepinephrine, cortisol, and β-endorphins — the post-plunge focus and energy effect is mechanistically tied to norepinephrine, which directly regulates alertness, per a synthesis citing a Journal of Neuropsychiatry and Clinical Neurosciences meta-analysis and a Scientific Reports RCT (AOL/Yahoo).
A 500× dopamine claim circulates widely in cold plunge marketing (sourced to Plunge internal data, not peer-reviewed); the controlled-study figure is a meaningful but substantially smaller noradrenaline surge. Evidence-supported protocol consensus: 50–60°F water, 3–5 minutes once tolerance is established.
Get Biohacking Therapies & Devices in your inbox
Subscribe to receive new issues as they're published.